Gujarat : Death Toll Reaches Seven In Kheda Syrup Scam, Mumbai Supplier Arrested

Ahmedabad : Another casualty has been reported at an Ahmedabad government hospital, marking the death toll at seven in the Kheda Syrup scam in Gujarat. Additionally, Kheda police have apprehended a supplier from Mumbai linked to the accused operating a syrup factory in Nadiad.

The latest victim, 72-year-old Sankar Sodha, succumbed at the government hospital in Ahmedabad. He fell ill after consuming the ayurvedic syrup, initially receiving treatment at a Nadiad hospital before being referred to the Ahmedabad government hospital. Despite four days of treatment, he succumbed early Wednesday morning

Yogesh Sindhi, one of the five accused in the syrup scandal, has been divulging critical information during police interrogation while on remand.

Kheda police conducted a search at Yogesh Sindhi’s factory near Nadiad’s Mokumpura on Monday, seizing numerous bottles filled with the syrup and chemicals from the premises.

According to Sindhi’s statement to the police, he learned about manufacturing the syrup from an acquaintance while serving a sentence in another case. Upon release, he established a factory, building a network across central Gujarat and expanding his market. To produce the syrup, he required Ethanol, establishing a business relationship with Taufiq, a Mumbai-based supplier.

The Kheda SIT team apprehended Taufiq in Mumbai, slated to appear before the court on Thursday.

In connection to the scam, Vadodara police handed over two other key players, Nitin Kotwani and Bhavesh Saukani, to Kheda police. The trial court granted a 12-day remand for both accused on Wednesday.

Kotwani and Saukani have a criminal history associated with manufacturing similar syrups. They were previously arrested by Rajkot police in Maharashtra’s Nandurbar, leading to the sealing of their factory.

Related Posts

India’s Pharma Sector Must Expand AI Use Beyond R&D: Reports

The report emphasizes that absolute R&D spending remains modest and identifies expanding investment in advanced biologics and AI-driven drug discovery as the “largest opportunity” for bridging the innovation divide. Recent…

India’s Pharma, Healthcare Funding Hits $38.6 Mn in Nov’25

Early-stage activity drove the month, accounting for 73.6 per cent of total investments, while seed-stage rounds contributed the remaining 26.4 per cent. India’s pharma and healthcare funding for November 2025…

Leave a Reply

Your email address will not be published. Required fields are marked *

You Missed

India’s Pharma Sector Must Expand AI Use Beyond R&D: Reports

India’s Pharma Sector Must Expand AI Use Beyond R&D: Reports

India headed for Culture of ‘Divya Buildings’, thanks to AMTZ’s Landmark Initiative

India headed for Culture of ‘Divya Buildings’, thanks to AMTZ’s Landmark Initiative

India’s Pharma, Healthcare Funding Hits $38.6 Mn in Nov’25

India’s Pharma, Healthcare Funding Hits $38.6 Mn in Nov’25

Novo Nordisk gears up for December Ozempic launch

Novo Nordisk gears up for December Ozempic launch

Illegal intoxicant tablets seized in large quantity from Sirsa medical store, two held

Illegal intoxicant tablets seized in large quantity from Sirsa medical store, two held

Higher pharma, chemicals exports to Russia bloc on agenda to trim deficit

Higher pharma, chemicals exports to Russia bloc on agenda to trim deficit